Full Text
 
Advanced Search
Work has begun on improving our website! Close the message box
Our website is evolving and our goal is to create a great user experience for our readers and authors. You will see regular enhancements to our site in the coming months.
Please visit our news site for further information.

Rapid publication of high quality organic chemistry research
Impact Factor 3.559 48 Issues per Year Indexed in Medline
Communication

Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma

*
Corresponding authors
a
Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, USA
E-mail: szhang2@vcu.edu
b
School of Chemistry and Pharmaceutical Engineering, Shandong Polytechnic University, Jinan, P.R. China
c
Department of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, USA
d
Department of Internal Medicine and Massey Cancer Center, Virginia Commonwealth University, Richmond, USA
Org. Biomol. Chem., 2013,11, 4757-4763

DOI: 10.1039/C3OB40595H
Received 25 Mar 2013, Accepted 07 Jun 2013
First published online 11 Jun 2013
Please wait while Download options loads
 
 

Supplementary Info

Additions & Corrections